AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com

Moderna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com

Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com

August 19, 2026 at 12:17 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

Germany USA

Tags

biotech clinical trial healthcare melanoma merck moderna stocks vaccine

All Coverage

Moderna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOV1VaQ05TQmRfMmJzTUkwU2puSHBUcE9FdzY2OW5SaXVFc2FpR25rclJEY1NHS1lrYWdaWE5OUVdhZ2VfTGVHak45akZnYm0wbEZVdXpOYjJEYkpVc3VXaDRrQnZBMDlJbWJLZUY2M2dFc0lycDc1LUtiSmxEWnlsVThSY1RRRG5WM050bEZLR1puWlhDMGlJczRZM0tXb2lHYzlSSmxTRFlQdm52THFDbG1zZlBWLUNUZG9qVjFoQlI?oc=5" target="_blank">Moderna shares surge as melanoma vaccine with Merck succeeds in large trial</a>&nbsp;&nbsp;<font color="#6f6f6f">reuters.com</font>

100%

Similar Stories

Related coverage based on topic and tags

Moderna to replace Warner Bros Discovery on Nasdaq 100 - Reuters

Moderna to replace Warner Bros Discovery on Nasdaq 100 Reuters

October 2, 2026 at 12:12 AM

AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters

AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters

October 2, 2026 at 06:58 AM

UniQure plunges as Huntington's trial data disappoints investors - reuters.com

UniQure plunges as Huntington's trial data disappoints investors reuters.com

September 29, 2026 at 10:11 PM

Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters

Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters

September 28, 2026 at 04:14 PM

AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters

AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters

September 28, 2026 at 10:15 PM

AbbVie joins US government pilot to test drug discount rebates - Reuters

AbbVie joins US government pilot to test drug discount rebates Reuters

October 2, 2026 at 08:53 PM